Dr Reddy's gets USFDA go-ahead

Dr Reddy's Laboratories has been granted the final approval to sell 150 mg anti-ulcer ranitidine tablet in the US market, according to the US Food and Drug Administration. The company has been selling ranitidine in the US in other forms and potencies for sometime now.